The MiniMed 780G with Guardian 4 and a 7-day infusion set. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced today that Medicare now covers its new MiniMed 780G system with the Guardian 4 ...

Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes ...

Two years after submitting the MiniMed 780G system for FDA approval, Medtronic finally secured the agency’s signoff to begin selling it in the U.S.

Medtronic MiniMed users whose insulin pumps fall outside the four-year warranty period can still exchange devices for a $500 credit toward the 780G. People using an in-warranty pump from another ...

The next-gen MiniMed 780G system. [Image from Medtronic] Medtronic (NYSE:MDT) Canada announced today that Health Canada granted a license to its MiniMed 780G automated insulin delivery system. The ...

Dive Brief: Medtronic has issued an Urgent Medical Device Correction for its MiniMed 600 series insulin pump system after discovering an issue that could result in unauthorized access. After gaining ...

The FDA has issued an alert warning people with diabetes using a Medtronic MiniMed 630G or MiniMed 670G insulin pump of a possible cybersecurity risk, according to an agency press release.

Medtronic's Adapt trial put the algorithm-equipped MiniMed 780G insulin pump to the test against one standard of care for Type 1 diabetes.

(RTTNews) - Medtronic plc (MDT) on Thursday reported results from the ADAPT study of its MiniMed 780G insulin pump, that continuously monitors and automatically adjusts insulin dosages round the ...

The U.S. Food and Drug Administration is reminding patients who use the popular 600-series MiniMed insulin pumps made by Medtronic that the devices contain an issue that could cause their buttons ...